Neuroinflammation is known to contribute to the development of neurodegeneration in e.g. TBI and CTE (Johnson et al., 2013, Erturk et al., 2016), and in AD, microglial activation occurs before tau aggregation, neuronal loss, and behavioral dysfunction (Dani et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.